Immunology Flashcards

1
Q

ALPS dx

A

Lymphoproliferation, cytopenias, LN/splenomegaly

Required
- >6mo nonmalignant/inf LN or splenomeg
- elevated DNT cells

Accessory
- defective lymphocyte apoptosis
- somatic/germline mutation FAS, FASLG, CASP10
- elevated plasma sFASL or IL-10 or B12 or IL-18
- IHC findings
- autoimm cytopenias and elevated IgG
- FHx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALPS Evans Syndrome - epi, tx

A

50% of ALPS have Evans

steroid + IVIG
pulse MP –> pred maintenance
+- MMF or sirolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

1o Immunodeficiency red flags

A

4 AOM/y
FHx
FTT
fungal inf
2 pneumonia
2 sinus infection/y
2 mo IV atb
2 deep seated inf
recurrent deep skin inf
IV atb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

components of innate and adaptive immunity

A

Innate
- physical barriers, complement, cytokines, fever, mucous
- neutrophils
- macrophage
- NK
- eosinophil

Adaptive
- T CD8 cytotoxic
- T CD4 helper
- B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

immunodefic workup

A

quantitative: CBC, B/T subsets, Ig, complement

Qualitative:
- T: mitogen stimulation, TCR beta repertoire
- B: Ig, CD40L (class switching), vaccine titre

Other
- CXR (thymus)
- TREC (SCID)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

neonatal Ig physiologic nadir

A

IgG 2-6mo
IgA/M increase from birth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SCID definition and screening

A

low/absent fxnl T cells (CD3 <300/uL)
+- nonfxnl B cells

absent TREC (T cell repertoire excision circles) on NBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SCID presentation

A

thrush, severe viral, opportunistic, live vaccine infection

FTT
chronic diarrhea
rash
lack of thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T-B-NK- SICD types

A

ADA
Adenylate kinase 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T-B-NK+ SCID types

A

RAG1 and RAG2
DCLRE1C (artemis)
DNA ligase IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T-B+NK-

A

X linked SCID
JAK3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T-B+NK+ SCID

A

IL-7 receptor alpha (CD127)
T cell Ag receptor complex
CD45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADA SCID type

A

T-B-NK-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Artemis (DCLRE1C) SCID

A

T-B-NK+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

X linked SCID type

A

T-B+NK-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Omenn Syndrome

A

edema, fluid overload, inflammation, LN, rash

17
Q

SCID supportive mgt

A

proph: Septra, fluc, IVIG
viral PCR surveillance
no BF until Mom CMV neg
protective isolation
SW
irradiated blood products

18
Q

SCID HSCT

A

ASAP, ideally <3mo
MSD goal

MSD - no conditioning
haplo - no conditioning, T cell depletion
MUD - condition

19
Q

SCID gene therapy

A

Bu conditioning

trial for ADA w lentiviral vector: OS 100%, immune reconstitution 96%

20
Q

XLA mutation and pathophys

A

BTK (bruton tyrosine kinase) mutation -> pre-B cell arrest -> no Ab

21
Q

XLA presentation

A

present at 6mo after maternal IgG nadir with
- recurrent bacterial infections
- chronic enteroviral meningoencephalitis
- vaccine associated paralytic poliomyelitis

22
Q

XLA malig risk

A

lymphoproliferative malig
gastric, colorectal adenocarcinoma
SCC lung

23
Q

XLA ix

A

flow low/absent CD19
absent Ig
neg vaccine titres
absent tonsil/adenoid/lymph tissue
BTK mutation testing

24
Q

XLA tx

A

IVIG
+- atb proph

HSCT if refractory

25
WAS triad and genetics
eczema microthrombocytopenia immunodeficiency - combined T/B - high IgA/E - lack of carbohydrate vaccine response WASP gene (Xp11) - flow cytometry
26
WAS malig risk
NHL other EBV-driven B L+L 10-20% risk
27
WAS tx
HSCT - best <5yo w MSD
28
XLP genetics, presentation, tx
XLP1 = SH2D1A mutation XLP2 = BIRC4 mutation HLH post EBV inf fatal infectious EBV aplastic anemia pulm lymphoid granulomatosis hypogamm HSCT - outcomes 80%, but 50% if active HLH
29
CVID pathophys, presentation, dx, tx
humoral defect due to lack of plasma cell differentiation sinopulmonary chronic enteroviral meningoencephalitis lymphoprolif autoimmunity flow low CD19 poor vaccine response IVIG
30
AT features, genetics, malig risk
progressive cerebellar ataxia oculocutaneous telangiectasia immunodeficiency (sinopulm) aut rec ATM mutation lifetime malig risk 30-40% L+L (T cell, DLBCL) carcinoma: breast, gastric, thyroid, liver
31
Chediak Higashi presentation, inheritance, immune issue, dx
partial oculocutaneous albinism frequent bacterial infections progressive neuro dysfunction mild-mod neutropenia aut rec CHS1 mutation profound NK/T cell, monocyte, lymphocyte dysfxn giant lysosomal granules in blood/BM
32
giant lysosomal granules suggests
Chediak Higashi
33
Hyper IgE features, genetics
sinopulmonary eczema retained primary teeth coarse facial features STAT3 defic (aut dom) DOCK8 defic (aut rec)
34
#1 immunodeficiency
selective IgA deficiency
35
hyperIgM pathophys and tx
X linked CD40L deficiency -> no class switching -> no IgA/G IVIG, Septra HSCT